A Novel Approach for Oral Delivery of Insulin via Desmodium gangeticum Aqueous Root Extract by Kurian, GA et al.
156   J Young Pharm Vol 2 / No 2
armamentarium of treatments for DM in the last decade. The 
goal of all treatments is the same irrespective of the cause of 
the DM, namely to normalize blood glucose. Insulin therapy 
affords effective glycemic control, yet its short comings 
such as ineffectiveness on oral administration, short shelf 
life, and requirement of constant refrigeration.[1] Treatment 
with sulfonylureas and biguanides is also associated with side 
effects.[2] However, recently numerous researches are being 
carried out to reduce the limitations of insulin therapy.
Researchers are trying to find various alternatives to deliver 
INTRODUCTION
Insulin is a natural hormone which controls the level 
of blood glucose and are limited in tissues of diabetes 
mellitus (DM)-induced rats. Patients with Type 2 DM are 
insulin resistant, have relatively low insulin production, or 
both. Some patients with Type 2 diabetes may eventually 
require insulin when other medications fail to control blood 
glucose levels adequately.
Many new pharmacological agents have been added to our 
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ABSTRACT
Many challenges are associated with the oral delivery of insulin, relating to the physical and chemical stability 
of the hormone, and its absorption and metabolism in the human body. The present study aims to demonstrate 
the oral delivery of insulin in both normal and steptozotocin (STZ)-induced diabetic rats with the help of the 
aqueous extract of Desmodium gangeticum (DG) root. Human insulin was mixed with the aqueous extract of DG 
root (0.1 mg/ml) with human insulin (40 IU/ml) in ratio 1:1(v/v), to prepare oral insulin drug. Decreased plasma 
glucose level and increased plasma insulin in normal and STZ-induced diabetic rat suggested the probable 
absorption of insulin through GI tract when insulin was administered by mixing with DG extract. Indeed, insulin 
mixed DG potentially stimulates the release of insulin in STZ-induced diabetic rat rather than in normal animal. 
In vivo insulin secretaguage action of oral insulin drug was determined by isolated rat heart model and the results 
showed a significant cardio protection in STZ rat. The finding of this study suggests that insulin mixed with DG 
extract can be a promising vehicle for oral delivery of insulin. However, further studies are required to explore 
the exact compound(s) responsible for the protective delivery of insulin orally. Increased plasma insulin level 
by insulin mixed DG extract administration in STZ-treated diabetic rat indicates not only insulin secretaguage 
action of the mixture but also a probable altered insulin release mechanism in diabetic condition.   
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insulin via noninvasive routes, such as nasal,[3] rectal,[4] 
pulmonary,[5] and ocular deliveries.[6] However, among all 
alternative routes for the administration of insulin, the oral 
route is the most convenient. In addition, because orally 
administered insulin undergoes a first hepatic pass, it will 
produce a similar effect as pancreas-secreted insulin by 
inhibiting the hepatic gluconeogenesis and suppressing the 
hepatic glucose production.[7] Unfortunately, oral delivery 
of peptides or proteins such as insulin poses unique 
problems of instability, susceptibility to proteolysis, and 
inability to traverse membranes and biological barriers 
due to their large molecular size.[8] As a result, the absolute 
amount of intact protein reaching the target site is too small 
to be of pharmacological benefit. To overcome these major 
problems, it was suggested to increase the oral absorption 
of insulin to circumvent the digestion of this polypeptide 
in the gastrointestinal (GI) tract by entrapping insulin 
in polymeric microspheres[9] or by coating with polymer 
films.  [10] However, no study has been done to transport 
insulin with the help of an herbal extract as a vehicle. 
Desmodium gangeticum (DG) (Leguminosae) is a shrub 
common on the lower hills and plains throughout India. 
DG is widely used in the indigenous system of medicine in 
India and is reported to contain flavone and isoflavonoid 
glycoside.[11] It forms the ingredient of many Ayurvedic 
formulations used for diabetes. Moreover, it strengthens 
the nervous system, improves digestion, and secretion of 
digestive enzymes.[11] It also acts as diuretics. In this study 
we used insulin mixed with an extract (aqueous) obtained 
from DG root as a vehicle to transport insulin across the 
GI tract. 
MATERIALS AND METHODS
Preparation of aqueous extract of the roots of Desmodium 
gangeticum
The plant after collection from the herbal garden 
maintained in the department was washed and cleaned. The 
plant material was taxonomically identified and the voucher 
specimen A/C no. 3908 was retained in our laboratory for 
future reference. 
One kilogram (1 kg) of fresh secondary roots of DG 
were sliced and air-dried at room temperature. The 
sliced, air-dried roots of the plant were milled into fine 
powder. Soxhlet extraction with 2.5 l of distilled water 
at room temperature for 24 h with shaking was used to 
obtain the extracts. The aqueous extracts were filtered 
and concentrated to dryness under reduced pressure at 
30±1
o
C. The resulting aqueous extract was freeze-dried, 
finally giving 18.66 g [i. e., 1.866% yield]. Aliquot portions 
of the crude root aqueous extract residue were weighed 
and dissolved in distilled water for the experiment. 
Animals
Male wistar rats (170-190 g) were procured from King 
Institute of Preventive Medicine, Chennai, India, and used 
for the investigation of oral delivery of insulin via DG. 
These studies were approved by the Institutional animal 
ethical committee (IAEC). The animals were housed under 
standard conditions of temperature (22±3° C) and relative 
humidity (30-70%) with a 12:12 light: dark cycle. The 
animals were fed with standard pellet diet (Amrit Feeds 
Ltd, Bangalore.) and water ad libitum. Animals were fasted 
for 18–24 h and streptozotocin (STZ; 65 mg/kg) in 0.02 
M citrate saline buffer was administered intraperitoneally, 
as described previously.[12] A blood glucose level exceeding 
200 mg/dl was considered diabetic. 
Preparation of DG-mixed insulin
DG-mixed insulin mixtures were prepared by mixing the 
aqueous extract of DG (1 mg/ml) with human insulin (40 
IU/ml) in ratio 1:1(v/v). 
Oral glucose tolerance test
Oral glucose tolerance test was performed in normal and 
diabetic rats after an overnight fasted (18 h). Animals were 
randomized into following groups: (1) normal control; (ii) 
diabetic control; and (iii)drug group. In fact drug groups 
were again divided into two subgroups: (a) effect of drug 
on OGTT in normal rat and (b) effect of drug on OGTT 
in diabetic rats. Animals were fasted overnight and were 
placed in restraining cages for 30 min in the morning 
before commencing the study. Glucose was given orally 
by an esophageal tube as a 40% solution (1 g/kg body 
wt). The drugs were administered both intraperitoneal 
and oral routes. Blood was withdrawn from the orbital 
plexus of each animal at 0, 30, 60, 90,120, and 180 min 
after administration of the oral load. The fasting blood 
glucose levels were estimated by using standard kits 
from Qualigens India. Plasma insulin was analyzed by 
the IRMA method.
Isolated heart preparation and ischemia-reperfusion 
experiment for insulin secretogenic action
Rats were heparinized (500 IU/kg, i.p.) and anesthetized 
with pentobarbital (50 mg/kg, i.p.), and the heart was 
isolated and perfused retrogradely using the Langendorff 
method with Krebs-Henseleit buffer (pH 7.4, in mM) 
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118 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 
25.0 Na2HCO3, 11.0 glucose,) equilibrated with 95% O2 
and 5% CO2 gas mixture at 36.5°C at a constant pressure 
of 80 mmHg. The coronary perfusion pressure was 
maintained at 80 mmHg. The left ventricular pressure 
developed within ventricle filled with Krebs solution was 
recorded with a pressure transducer, which in turn was 
connected to a device amplifier and chart recorder. This left 
ventricular pressure gave an indication of the mechanical 
performance of the heart. Coronary flow was measured 
simply by collecting the perfusate draining from the heart 
in a graduated cylinder for a defined time. The heart rate 
was measured by counting the number of contractions 
(obtained from the left ventricular pressure record) per 
minute. 
Group A: Normal rat hearts (n=6) subjected to 70 min 
perfusion with KH buffer.
Group B: Normal rat hearts (n=6) subjected to 20 min 
global ischemia followed by 30 minutes reperfusion after 
20 min equilibration.
Group C: Diabetic rat hearts (n=6) subjected to 20 min 
global ischemia followed by 30 min reperfusion after 20 
min equilibration.
Group D: Normal rat hearts (n=6) were pretreated with 
oral insulin before 1 h of experiment and then subjected 
to IR injury similar to group B.
Group E: Diabetic rat hearts (n=6) were pretreated with 
oral insulin before 1 h of experiment and then subjected 
to IR injury similar to group C.
Group F: Normal rat hearts (n=6) were subjected to 20 
min global ischemia and oral insulin was given along with 
KH buffer prior to 30 min reperfusion.
Group G: Diabetic rat hearts (n=6) were subjected to 20 
min global ischemia and oral insulin was given along with 
KH buffer prior to 30 min reperfusion.
The coronary effluent during the 30 min of reperfusion 
period was collected for measurement of creatine kinase 
content (released CK) and lactate dehydrogenase. Lactate 
dehydrogenase (LDH) and creatine phosphokinase (CPK) 
were determined by the method of King[13] and Okinaka 
and his coworker,[14] respectively, using commercially 
available kit. Blood glucose was measured by the glucose-
oxidase method.[15] Insulin was assayed by the radio-
immunoassay kit method.
Statistical analysis
All data were reported as mean ± SD. Results were 
statistically analyzed by a one-way analysis of variance 
(ANOVA) by SPSS software 12.00, followed by Duncan’s 
multiple range test (DMRT). P< 0.05 was considered to 
be significant. 
RESULTS
Oral glucose tolerance test
The mean glucose response is presented in Figures 1 
and 2. In oral glucose tolerance test, the blood glucose 
level increased after glucose administration and reached 
a peak concentration at 60 min. Around 120 min after 
glucose administration, the blood glucose level decreased 
in normal and slightly declined in diabetic control rats. 
On comparison with intraperitoneal administered insulin, 
orally administrated insulin in the OGTT procedure did not 
reduce glucose concentration after 60 min. However, oral 
administration of DG-mixed insulin showed a significant 
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Figure 1: Glucose tolerance test in normal rats
Figure 2: Glucose tolerance test in diabetic ratsJ Young Pharm Vol 2 / No 2  159
decline in glucose level after 90 min. In fact, insulin mixed 
with 3 mg/ml of DG extract showed better result. In 
contrast, 1 h prior administration of drugs did not show 
any significant impact on the changes in pattern of glucose 
concentration.
Insulin and glucose level
Table 1 shows plasma insulin and glucose levels in 
normal and diabetic rats. In normal rats, plasma insulin 
concentrations were elevated when the insulin was given 
intraperitoneal and as insulin mixed with DG. A subsequent 
decline in blood glucose level confirms the activity of 
insulin delivered in both routes (intraperitoneal and oral). 
In fact, oral administration of insulin did not show any 
significant elevation of plasma insulin levels.
A similar pattern of results were observed in diabetic rats 
also. But, to our surprise the elevation of plasma insulin 
levels were much higher than that of normal animals when 
insulin-mixed DG was used as the vehicle to transport 
insulin. We predict that the above results may be due to 
insulin secretagouge action of DG-mixed insulin.
Isolated heart preparation and ischemia-reperfusion 
experiment
Absolute values of hemodynamic parameters were shown 
in Figures 3 and 4. Depressed physiological parameters in 
ischemia reperfusion control were recovered in rats that 
received DG-mixed insulin through both intraperitoneal 
and oral route. Interestingly, diabetic rats showed a better 
preservation of hemodynamic parameters like LVDP, heart 
rate and RPP, when they were given DG-mixed insulin 
(both intraperitoneal and oral route administered drug) 
than normal rats. 
Tables 2 and 3 show the amount of released CK and LDH 
during reperfusion stage of the experiment. When the heart 
was perfused with DG-mixed insulin, amount of released 
CK and LDH was found to be significantly lowered than 
normal ischemia reperfusion control. But the functional 
recovery of myocardium by DG-mixed insulin in terms 
of released LDH and CK was more significant in diabetic 
animal than normal animal. Cardiac enzymes in the tissue 
homogenate also complimented the above results.
DISCUSSION
The important findings of this study can be summarized 
as follows: (i) when aqueous extract of DG root was used 
as a vehicle to transport insulin, it not only helps insulin 
to get absorbed across the GI tract but also in active form; 
(ii) a significant increase in plasma insulin in diabetic rats 
as compared to normal rats when insulin was given along 
DG as a vehicle for oral insulin delivery
Table 1: Concentration of plasma insulin and plasma glucose in normal and diabetic rats treated with insulin and 
insulin-mixed DG
Groups Plasma insulin (Units/ml plasma)  Plasma glucose (mmol/l)
Normal rats
Normal a74± 8.3 a2.46± 0.2
Normal rats given insulin intraperitoneal route d102± 12.1* d1.23± 0.7*
Normal rats given insulin oral route a72± 8.3 a2.48± 0.5
Normal rats given aq. extract of DG(0.3 mg/kg b.wt) 
intraperitoneal route
a74± 6.7 a2.46± 0.3
Normal rats given aq. extract of DG(0.3 mg/kg b.wt) oral 
route
a75± 6.2 a2.42± 0.4
Normal rats given insulin-mixed DG (0.3 mg/kg b.wt) 
intraperitoneal route
d96± 8.6* d1.36± 0.2*
Normal rats given insulin-mixed DG(0.3 mg/kg b.wt) oral 
route
d90± 7.4* d1.45± 0.5*
STZ-induced diabetic rats
Diabetic control b50± 6.2 b7.89± 0.5
Diabetic rats given insulin oral b52± 4.7 b7.69± 0.9
Diabetic rats given insulin intraperitoneal a70± 6.3* a2.43± 0.9*
Diabetic rats given aq. extract of DG(0.3 mg/kg b.wt) 
intraperitoneal 
b57± 5.1 b7.52± 0.6
Diabetic rats given aq. extract of DG(0.3 mg/kg b.wt) oral b59± 5.3 b7.47± 0.5
Diabetic rats given insulin-mixed DG(0.3 mg/kg b.wt) 
intraperitoneal
c80± 7.3* c2.29± 0.2*
Diabetic rats given insulin-mixed DG(0.3 mg/kg b.wt) oral d97± 7.3* d1.60± 0.3*
Values are mean ± SD for six rats in each group, Significantly differ from normal control group (normal rats are compared with normal control and STZ induced rats with 
diabetic control) are expressed as (*) P< 0.01, Values not sharing a common superscript (a,b,c,d) differ significantly at P<0.05 when compared between the groups.160   J Young Pharm Vol 2 / No 2
Figure 3: Rate pressure product of hearts subjected to 30 minutes 
global ischemia followed by reperfusion in normal rats
Figure 4: Rate pressure product of hearts subjected to 30 minutes 
global ischemia followed by reperfusion in diabetes mellitus rats 
metabolic control of diabetic rats.[16] However, significant 
hypoglycemic action mediated by insulin-mixed DG 
administered by both intraperitoneal and oral route 
predicted either increased insulin level or increased half 
life of insulin in blood.
Plasma insulin glucose level
The hypoglycemic effect was taken as a monitor for insulin 
absorption in its physiologically active form. The results 
are shown in Table 1. When insulin-mixed DG was given, a 
significant reduction in plasma glucose along with increased 
plasma insulin in both normal and diabetic rats was 
observed, indicating a direct response of insulin. In normal 
rats, OGTT showed a prominent hypoglycemic effect at 30 
to 90 min and 60 to 120 min in insulin-mixed DG rats given 
intraperitoneal and oral route, respectively, and the effect 
was visible up to 180 min [Figure 1]. The maximum plasma 
glucose reduction (% of initial) was found to be 78% ± 
2% and the time to reach the maximum plasma glucose 
reduction was 1.30 and 2 h in intraperitoneal administered 
rats and oral administered rats, respectively. In fact, orally 
administered insulin at the same dose showed no reduction 
in blood glucose which indicates proteolytic degradation of 
insulin in the GI tract or presystemic metabolism. These 
results suggested that DG extract can not only protect 
insulin against in vivo proteolytic degradation but can also 
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Table 2: Activity of CK, LDH, SGOT, and SGPT in the tissue homogenate of isolated rat heart
Group CK (µmol phosphorous 
generated/min/mg protein)
LDH (nmol pyruvate 
generated /min/mg protein)
SGOT (nmol pyruvate generated /
min/mg protein)
SGPT (nmol pyruvate generated /min/
mg protein)
A a17.3± 1.3 a106.4 ± 7.2 a38.2 ± 2.1 a24.6± 1.6
B b8.7± 0.3 b60.1± 4.2 b18.2 ± 1.2 b15.5± 1.1
C b6.33±0.9 d40.6± 4.2 b19.67± 1.1 b14.23± 1.3
D c12.11± 2.1 b72.6± 8.1 b18.2± 1.3 b17.3± 2.1
E c10.52± 1.3 b52.6± 4.2 b20.3 ± 3.2 b16.6± 1.8
F c13.42± 1.3 c87.3±4.3 a32.2± 1.3 a21.2± 1.4
G  a15.46± 1.4 c88.6± 5.4 a32.4± 2.4 a23.3± 1.1
Values are mean ± SD for six rats in each group, Values not sharing a common superscript (a,b,c,d,) differ significantly at P<0.05) when compared between the groups. 
Table 3: Activity of creatine kinase and lactate 
dehydrogenase in the perfusate of isolated rat heart
Group CK (Units/ml/perfusate) LDH (Units/ml/perfusate)
A a175± 23.2 a70.1± 10.2
B b320± 43.3 b145.2± 20.4
C b330± 45.8 b155.6± 23.6
D c281± 22.6 c102.2± 14.9
E c290± 23.7 c125.5± 18.3
F d194± 22.8 c101.2± 20.8
G a172± 16.1 a87.5± 14.1
Values are mean ± SD for six rats in each group. Values not sharing a common 
superscript (a,b,c,d,) differ significantly at P<0.05) when compared between the 
groups
with its vehicle predicted a probable insulin secretagouge 
action of DG-mixed insulin and (iii) oral administration of 
insulin along with DG aqueous extract showed significant 
cardio protection to ischemia reperfusion injury in rats. 
Oral Glucose tolerance test
Steptozotocin-induced diabetic rats presented significant 
hyperglycemia as compared to normal rats in OGTT 
analysis. Intraperitoneal administration of insulin, insulin 
along its vehicle, and oral administration of insulin-mixed 
DG normalizes the blood glucose level after 90/120 min 
[Figures 1 and 2]. These findings are in agreement with 
the literature that indicates that insulin normalizes the J Young Pharm Vol 2 / No 2  161
studies need to be carried out to find the exact compound 
and mechanism involved in the above findings.
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preserve the biological activity of insulin. Numerous 
works have reported that on hypoglycemic activity of 
insulin loaded with nanosphere,[17] microsphere,[18] and 
other vehicle, none of the interventions were effective as 
compared to insulin administered directly to blood.
However, in diabetic rats, hypoglycemic effect mediated 
by DG-mixed insulin was more significant as compared to 
normal rats [Table 1]. It is worth to mention here that DG 
extract can release insulin from Islet cells of Langerhans.  [19] 
Hence, the prominent level of plasma insulin in diabetic 
rats and the subsequent decline in plasma glucose level 
indicate insulin secretagogue action of DG extract. 
However, the reason for significant insulin secretagogue 
action of DG-mixed insulin in diabetic rat is highly 
debatable as we could not find similar action in normal rats. 
Moreover, administration of DG extract alone was unable 
to increase the plasma insulin level significantly. From the 
above observation, we suspect a change in metabolic release 
of insulin in diabetic rats, which needs to be proved further.
Isolated heart preparation and ischemia-reperfusion 
experiment
In vivo physiological activity of insulin in DG-mixed 
insulin was assessed in an experimental model for 
ischemia reperfusion injury (IRI)-induced diabetic rat 
heart. Hyperglycemic conditions significantly exacerbate 
the anomalies associated with IRI[20] and block the cardio-
protective effect mediated by glucose insulin potassium. 
Functional recovery of rat heart treated with DG-mixed 
insulin measured through hemodynamic parameters 
suggested myocardial protection.
The decreased activities of CPK, LDH, AST, and ALT in 
the myocardium and corresponding increase of cardiac 
markers in the perfusate are one of the indicators for 
cardiac injury associated with ischemia reperfusion, 
shown in ischemia reperfusion control rats. Oral and 
intraperitoneal administration of DG-mixed insulin 
significantly reduced the CK and LDH levels in perfusate, 
indicating the preservation of myocardial architecture 
during ischemia reperfusion.
CONCLUSION
The present study showed an innovative approach to 
administered insulin through oral route. In fact this study 
also provide clue for the difference in the insulin secretion 
mechanism in normal and diabetic rats. However, further 